Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2007; 13(32): 4394-4397
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4394
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4394
WBC | 5300 /μL | Total bilirubin | 0.6 mg/dL | HCV-Ab | Positive |
Hb | 11.0 g/dL | Direct bilirubin | 0.1 mg/dL | HCV-RNA | 4600 kIU/L |
Plt | 452 × 103 /μL | Total protein | 7.7 g/dL | HCV genotype | Ib |
PT | 101.8% | Albumin | 4.2 g/dL | HBs-Ag | Negative |
BUN | 16 mg/dL | HBs-Ab | Negative | ||
Creatinine | 0.8 mg/dL | ANA | × 80 | ||
AST | 39 IU/L | Uric acid | 3.4 mg/dL | ASMA | Negative |
ALT | 47 IU/L | Na | 140 mEq/L | AMA | Negative |
LDH | 176 IU/L | K | 4.5 mEq/L | IgG | 1635 mg/dL |
ALP | 278 IU/L | Cl | 104 mEq/L | IgA | 108 mg/dL |
γ-GTP | 11 IU/L | Total cholesterol | 133 mg/dL | IgM | 283 mg/dL |
ChE | 386 IU/L | Glucose | 77 mg/dL | HLA-DR | DR17/DR13 |
allele | DRB1*0301/*1302 |
WBC | 5800/μL | BUN | 5.0 mg/dL | ANA | × 160 |
Hb | 12.2 g/dL | Creatinine | 0.7 mg/dL | ASMA | Negative |
Plt | 290 × 103 /μL | Uric acid | 2.8 mg/dL | LKM-1 | Positive |
PT | 41.4% | Na | 138 mEq/L | AMA | Negative |
APTT | 44.4 sec | K | 3.9 mEq/L | IgG | 2436mg/dL |
Cl | 105 mEq/L | IgA | 175 mg/dL | ||
Total cholesterol | 175 mg/dL | IgM | 280 mg/dL | ||
AST | 311 IU/L | Triglyceride | 67 mg/dL | ||
ALT | 280 IU/L | Glucose | 127 mg/dL | ||
LDH | 245 IU/L | CRP | 0.2 mg/dL | HCV-RNA | 13 kIU/l |
ALP | 571 IU/L | HBs-Ag | Negative | ||
γ-GTP | 108 IU/L | Tyrosin | 262 μmol/L | HBs-Ab | Negative |
ChE | 124 IU/L | BCAA | 313 μmol/L | HBc-Ab IgM | Negative |
Total bilirubin | 5.5 mg/dL | HAV | Negative | ||
Direct bilirubin | 3.3 mg/dL | TSH | 0.499 μIU/mL | EBV | Negative |
Total protein | 7.4 g/dL | T3 | 1.66 pg/mL | HSV | Negative |
Albumin | 3.1 g/dL | T4 | 0.55 ng/dL | CMV | Negative |
- Citation: Kogure T, Ueno Y, Fukushima K, Nagasaki F, Inoue J, Kakazu E, Matsuda Y, Kido O, Nakagome Y, Kimura O, Obara N, Wakui Y, Iwasaki T, Shimosegawa T. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. World J Gastroenterol 2007; 13(32): 4394-4397
- URL: https://www.wjgnet.com/1007-9327/full/v13/i32/4394.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i32.4394